We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$365M
AUM Growth
+$48.9M
Cap. Flow
+$48.2M
Cap. Flow %
13.21%
Top 10 Hldgs %
51.36%
Holding
54
New
2
Increased
24
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$14M
2
NEO icon
NeoGenomics
NEO
+$13.3M
3
CSII
Cardiovascular Systems, Inc.
CSII
+$11.2M
4
NVRO
NEVRO CORP.
NVRO
+$7.68M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$6.76M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$8.16M
2
NKTR icon
Nektar Therapeutics
NKTR
+$5.97M
3
IMMU
Immunomedics Inc
IMMU
+$4.33M
4
MGNX icon
MacroGenics
MGNX
+$1.46M
5
STRM
Streamline Health Solutions
STRM
+$590K

Sector Composition

Rank Sector Weight
1 Healthcare 84.02%
2 Communication Services 4.08%
3 Energy 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
26
Bio-Techne
TECH
$11.2B
$4.93M 1.35%
152,284
-2,332
-2% -$74.1K
KTWO
27
DELISTED
K2M Group Holdings, Inc
KTWO
$4.87M 1.34%
270,758
-4,415
-2% -$83.8K
HSTM icon
28
HealthStream
HSTM
$819M
$4.85M 1.33%
209,587
+10,344
+5% +$244K
NXTM
29
DELISTED
NxStage Medical Inc.
NXTM
$4.67M 1.28%
192,670
+9,078
+5% +$239K
LHCG
30
DELISTED
LHC Group LLC
LHCG
$4.21M 1.16%
68,807
+4,135
+6% +$273K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$3.46M 0.95%
23,057
-364
-2% -$53.9K
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.78M 0.76%
31,213
-689
-2% -$59.9K
IRIX icon
33
IRIDEX
IRIX
$14.3M
$2.42M 0.66%
317,799
+79,004
+33% +$676K
STRM
34
DELISTED
Streamline Health Solutions
STRM
$2.32M 0.64%
91,670
-25,710
-22% -$590K
IBB icon
35
iShares Biotechnology ETF
IBB
$9.34B
$2.27M 0.62%
21,291
– –
IONS icon
36
Ionis Pharmaceuticals
IONS
$8.6B
$2.1M 0.58%
41,847
-664
-2% -$36.4K
ENZ
37
DELISTED
Enzo Biochem, Inc.
ENZ
$1.93M 0.53%
237,054
+11,438
+5% +$109K
XLVS
38
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.7M 0.47%
17,285
– –
ALKS icon
39
Alkermes
ALKS
$8.22B
$1.62M 0.44%
29,533
-554
-2% -$28.3K
XLV icon
40
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.51M 0.41%
18,241
– –
LMAT icon
41
LeMaitre Vascular
LMAT
$2.32B
$1.47M 0.4%
46,119
-697
-1% -$23.9K
CELG
42
DELISTED
Celgene Corp
CELG
$1.41M 0.39%
13,512
-344
-2% -$38.8K
MGNX icon
43
MacroGenics
MGNX
$235M
$1.4M 0.38%
73,558
-78,112
-52% -$1.46M
IHI icon
44
iShares US Medical Devices ETF
IHI
$3.13B
$1.31M 0.36%
45,480
– –
XBI icon
45
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$806K 0.22%
9,499
– –
ABBV icon
46
AbbVie
ABBV
$443B
$402K 0.11%
4,159
– –
PFE icon
47
Pfizer
PFE
$143B
$310K 0.09%
9,020
– –
JNJ icon
48
Johnson & Johnson
JNJ
$618B
$305K 0.08%
2,183
– –
DYNT
49
DELISTED
Dynatronics Corp
DYNT
$301K 0.08%
20,876
+471
+2% +$5.91K
NVS icon
50
Novartis
NVS
$297B
$300K 0.08%
3,986
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, First Light Asset Management held 54 positions worth $365M, up 15% from $316M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

First Light Asset Management deployed $48.2M of net new capital in Q4 2017, opening 2 new positions and adding to 24 existing holdings. Its largest new stake was Xencor: 644,764 shares worth $14.1M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Nektar Therapeutics, an estimated $5.97M trimmed.

  • First Light Asset Management's largest Q4 2017 buy was Xencor: 644,764 shares worth $14.1M.
  • First Light Asset Management added most to NeoGenomics in Q4 2017, an estimated $13.3M increase.
  • First Light Asset Management's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $5.97M.
  • First Light Asset Management fully exited Medicines Co in Q4 2017, selling an estimated $8.16M.
  • First Light Asset Management's ten largest holdings make up 51% of its $365M portfolio in Q4 2017.
  • First Light Asset Management opened 2 new positions and closed 2 in Q4 2017.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $365M.

Based on First Light Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.